10 Einträge gefunden

1. B cell maturation antigen-specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma

   1. Gagelmann, Nico
   2. Ayuk, Francis
   3. Atanackovic, Djordje
   4. Kröger, Nicolaus

   2020 - Forschungsinformationssystem des UKE
2. Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma

   1. Yousef, Sara
   2. Heise, Johanna
   3. Lajmi, Nesrine
   4. Bartels, Katrin
   5. Kröger, Nicolaus
   6. Luetkens, Tim
   7. Atanackovic, Djordje

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
3. Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma

   1. Lajmi, Nesrine
   2. Luetkens, Tim
   3. Yousef, Sara
   4. Templin, Julia
   5. Cao, Yanran
   6. Hildebrandt, York
   7. Bartels, Katrin

   2015 - Forschungsinformationssystem des UKE
4. Immune-modulating drugs and hypomethylating agents to prevent or treat relapse after allogeneic stem cell transplantation

   1. Kröger, Nicolaus
   2. Stübig, Thomas
   3. Atanackovic, Djordje

   2014 - Forschungsinformationssystem des UKE
5. Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study.

   1. Wolschke, Christine
   2. Stübig, Thomas
   3. Hegenbart, Ute
   4. Schönland, Stefan
   5. Heinzelmann, Marion
   6. Hildebrandt, York
   7. Ayuketang Ayuk, Francis

   2013 - Forschungsinformationssystem des UKE
6. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.

   1. Pabst, Caroline
   2. Zustin, Jozef
   3. Jacobsen, Frank
   4. Luetkens, Tim
   5. Kröger, Nicolaus
   6. Schilling, Georgia
   7. Bokemeyer, Carsten

   2010 - Forschungsinformationssystem des UKE
7. Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up.

   1. Shimoni, Avichai
   2. Hardan, Izhar
   3. Ayuketang Ayuk, Francis
   4. Schilling, Georgia
   5. Atanackovic, Djordje
   6. Zeller, Wolfgang
   7. Yerushalmi, Ronit

   2010 - Forschungsinformationssystem des UKE
8. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.

   1. Kröger, Nicolaus
   2. Badbaran, Anita
   3. Lioznov, Michael
   4. Schwartz, Sabine
   5. Zeschke, Silke
   6. Hildebrandt, York
   7. Ayuketang Ayuk, Francis

   2009 - Forschungsinformationssystem des UKE
9. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.

   1. Atanackovic, Djordje
   2. Luetkens, Tim
   3. Hildebrandt, York
   4. Arfsten, Julia
   5. Bartels, Katrin
   6. Horn, Christiane
   7. Stahl, Tanja

   2009 - Forschungsinformationssystem des UKE
10. Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.

    1. Kröger, Nicolaus
    2. Zabelina, Tatjana
    3. Ayuketang Ayuk, Francis
    4. Atanackovic, Djordje
    5. Schieder, Heike
    6. Renges, Helmut
    7. Zander, Axel R.

    2006 - Forschungsinformationssystem des UKE